BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6980007)

  • 1. Chemotaxis in yersinia arthritis. In vitro stimulation of neutrophil migration by HLA--B27 positive and negative sera.
    Repo H; Leirisalo M; Tiilikainen A; Laitinen O
    Arthritis Rheum; 1982 Jun; 25(6):655-61. PubMed ID: 6980007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotaxis in yersinia arthritis. HLA-B27 positive neutrophils show high stimulated motility in vitro.
    Leirisalo M; Repo H; Tiilikainen A; Kosunen TU; Laitinen O
    Arthritis Rheum; 1980 Sep; 23(9):1036-44. PubMed ID: 7417352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphonuclear leucocyte function and previous yersinia arthritis: correlation of enhanced superoxide production with late manifestations.
    Repo H; Koivuranta-Vaara P; Leirisalo-Repo M
    Ann Rheum Dis; 1988 Jun; 47(6):452-7. PubMed ID: 2838004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of HLA-B27 positive and negative sera on migration of polymorphonuclear leukocytes in vitro.
    Repo H; Leirisalo-Repo M; Koskimies S
    Clin Exp Rheumatol; 1988; 6(3):227-31. PubMed ID: 3263238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced neutrophil migration in vivo HLA B27 positive subjects.
    Koivuranta-Vaara P; Repo H; Leirisalo M; Kiistala U; Osterman T; Vapaatalo H
    Ann Rheum Dis; 1984 Apr; 43(2):181-5. PubMed ID: 6370148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yersinia arthritis, immune functions and histocompatibility antigens.
    Repo H; Leirisalo-Repo M; Gripenberg M; Koskimies S; Kontiainen S; Laitinen O
    Acta Pathol Microbiol Immunol Scand C; 1986 Dec; 94(6):245-52. PubMed ID: 2953168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation and HLA-B27.
    Meri S; Partanen J; Leirisalo-Repo M; Repo H
    Ann Rheum Dis; 1988 Mar; 47(3):210-4. PubMed ID: 3258504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil function and HLA-B27. Superoxide production and yersinicidal activity of neutrophils from patients with previous yersinia arthritis.
    Repo H; Leirisalo-Repo M; Skurnik M; Tiilikainen A
    Med Biol; 1984; 62(2):91-4. PubMed ID: 6088912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphonuclear cell motility, ankylosing spondylitis, and HLA B27.
    Pease CT; Fordham JN; Currey HL
    Ann Rheum Dis; 1984 Apr; 43(2):279-84. PubMed ID: 6608924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil function and HLA-B27.
    Repo H; Leirisalo M; Koivuranta P; Osterman T; Kiistala U; Gahmberg CG; Vapaatalo H; Tiilikainen A; Laitinen O
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):168-71. PubMed ID: 6606470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation in Yersinia arthritis.
    Repo H; Meri S; Leirisalo-Repo M
    Contrib Microbiol Immunol; 1987; 9():141-4. PubMed ID: 3499289
    [No Abstract]   [Full Text] [Related]  

  • 12. Phagocyte function in reactive arthritis.
    Leirisalo-Repo M; Repo H
    Scand J Rheumatol Suppl; 1988; 76():73-7. PubMed ID: 3075090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superoxide dismutase isoenzymes, glutathione peroxidase and selenium in blood from HLA-B27-positive and -negative subjects.
    Marklund SL; Repo H; Koskimies S
    Acta Pathol Microbiol Immunol Scand C; 1987 Jun; 95(3):107-11. PubMed ID: 3498290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphonuclear leucocyte function and previous yersinia arthritis: enhanced chemokinetic migration and oxygen radical production correlate with the severity of the acute disease.
    Koivuranta-Vaara P; Leirisalo-Repo M; Repo H
    Ann Rheum Dis; 1987 Apr; 46(4):307-13. PubMed ID: 3592787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-B27, ankylosing spondylitis and polymorph motility.
    Pease CT; Currey HL
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):172-6. PubMed ID: 6606471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between HLA-B27 and clinical features in patients with yersinia arthritis.
    Laitinen O; Leirisalo M; Skylv G
    Arthritis Rheum; 1977 Jun; 20(5):1121-4. PubMed ID: 869958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis.
    Repo H; Jäättelä M; Leirisalo-Repo M; Hurme M
    Clin Exp Immunol; 1988 Jun; 72(3):410-4. PubMed ID: 3262459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil chemotaxis under agarose: a statistical analysis and comparison of the chemotactic response of cells from different donors.
    Repo H; Leirisalo M; Kosunen TU
    J Immunol Methods; 1981; 46(2):227-42. PubMed ID: 7310132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA phenotypes in patients with rheumatic fever, rheumatic heart disease, and Yersinia arthritis.
    Leirisalo M; Laitinen O; Tiilikainen A
    J Rheumatol Suppl; 1977; 3():78-83. PubMed ID: 266605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune function in patients with previous yersinia arthritis: lymphocyte responses to PHA and Staphylococcus aureus strain Cowan I.
    Repo H; Leirisalo-Repo M
    Acta Pathol Microbiol Immunol Scand C; 1986 Feb; 94(1):39-43. PubMed ID: 3487200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.